CR Analyses
| Variable . | CR Rate . | Univariate P Value3-150 . | Multivariate P Value . |
|---|---|---|---|
| inv16 or t(8; 21) | 37/39 (95%) | <.001 | .008 |
| Complex −5, −7 | 35/77 (45%) | <.001 | .008 |
| Other abnormal or IM | 160/253 (63%) | .23 | NS |
| Normal karyotype | 117/161 (73%) | .027 | — |
| PS ≤ 2 | 321/454 (71%) | <.001 | <.001 |
| PS > 2 | 28/96 (37%) | — | |
| LAFR | 273/308 (72%) | <.001 | <.001 |
| No LAFR | 126/222 (57%) | — | |
| IA | 64/78 (82%) | <.001 | — |
| IA + G | 107/143 (75%) | .007 | NS |
| F + A | 43/78 (55%) | .033 | NS |
| FLAG | 86/133 (65%) | .739 | NS |
| FLAG + Ida | 49/98 (50%) | <.001 | .034 |
| RAEB | 32/52 (62%) | .49 | NS |
| RAEB-t | 70/106 (66%) | .96 | NS |
| AML | 247/372 (66%) | .68 | — |
| Age | Decreases with increasing age | <.001 | .028 |
| AHD | Decreases with increasing length of AHD | <.001 | <.001 |
| Variable . | CR Rate . | Univariate P Value3-150 . | Multivariate P Value . |
|---|---|---|---|
| inv16 or t(8; 21) | 37/39 (95%) | <.001 | .008 |
| Complex −5, −7 | 35/77 (45%) | <.001 | .008 |
| Other abnormal or IM | 160/253 (63%) | .23 | NS |
| Normal karyotype | 117/161 (73%) | .027 | — |
| PS ≤ 2 | 321/454 (71%) | <.001 | <.001 |
| PS > 2 | 28/96 (37%) | — | |
| LAFR | 273/308 (72%) | <.001 | <.001 |
| No LAFR | 126/222 (57%) | — | |
| IA | 64/78 (82%) | <.001 | — |
| IA + G | 107/143 (75%) | .007 | NS |
| F + A | 43/78 (55%) | .033 | NS |
| FLAG | 86/133 (65%) | .739 | NS |
| FLAG + Ida | 49/98 (50%) | <.001 | .034 |
| RAEB | 32/52 (62%) | .49 | NS |
| RAEB-t | 70/106 (66%) | .96 | NS |
| AML | 247/372 (66%) | .68 | — |
| Age | Decreases with increasing age | <.001 | .028 |
| AHD | Decreases with increasing length of AHD | <.001 | <.001 |
Abbreviation: NS, not significant.
χ2 test.